Tag: Prostate cancer

Can what's on your plate keep prostate cancer in check? The evidence keeps growing. A new analysis of more than 6,000 prostate cancer patients found that men who followed the Mediterranean diet or the Alternative Healthy Eating Index lived longer after diagnosis. It builds on a Johns Hopkins study linking healthy diets with slower progression. keep reading

What if one of the biggest steps toward protecting the prostate starts at the dinner table? In a landmark study, men who followed a vegan diet, regular walks and stress reduction saw their PSA drop 4%, while PSA rose 6% in men who made no changes. Now the NCCN's 2026 survivorship guidelines say healthy living can lower the chance of some cancers coming back. keep reading

A PSA of 2.1 sounds like good news. For a small number of men, it is a disguise. Swedish researchers screened thousands of men and found clinically significant prostate cancer in the low-PSA range, detected only after MRI pointed to a suspicious lesion. Newer risk scores now aim to catch what a single PSA number misses. keep reading

PSA is just a protein. It leaks into the bloodstream from healthy and unhealthy prostate cells alike, which means a high reading can signal cancer or nothing at all. Miami researchers found that men eating the most healthful plant-based diets had the lowest odds of an elevated PSA, and a 2024 study extends that benefit even after treatment. keep reading

Most men treated for early prostate cancer are alive five years later, whatever option they choose. So why do about 1 in 7 look back with regret? The answer has less to do with survival and more to do with side effects nobody prepared them for, and with how the decision got made in the first place. New long-term data adds urgency to that question. keep reading

Most men over 45 grew up hearing that masturbation caused everything from blindness to acne. Harvard researchers found something closer to the opposite: men who ejaculated 21 times a month had a lower risk of prostate cancer than men who managed 4 to 7. A follow-up look at gene activity in prostate tissue hints at why that might be true. keep reading

Combining multiparametric MRI with genomic testing is revolutionizing prostate cancer detection and treatment. By leveraging the strengths of both technologies, doctors can achieve more accurate diagnoses, guide personalized treatment decisions, and improve patient outcomes. Learn how these tools are shaping the future of prostate cancer care. keep reading

Did you know over 95% of prostate cancers share the same name—adenocarcinoma? This common cell type is usually slow-growing, but not always. Understanding how it develops, why PSA levels matter, and what early detection can reveal is key to knowing your best treatment options. keep reading

Should every man on active surveillance be monitored the same way? New evidence suggests genetics may hold the answer. Polygenic risk scores could one day refine prostate cancer protocols, helping patients get care that matches their unique risk. keep reading

There's a saying that less is more. For men with intermediate-risk prostate cancer weighing hormone therapy on top of radiation, that phrase turns out to be more than a proverb. Five-year results from a landmark 1,492-patient trial found better cancer control in the combined group, no survival difference, and a real cost in side effects. keep reading